Newsmeme!
Discover News you didn't know existed
Rheumatoid Factor
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Chugai Pharma Falls After FDA Seeks Data on Actemra (Update3)
Published December 4, 2008, 11:09 pm, Bloomberg
Dec. 5 (Bloomberg) -- Chugai Pharmaceutical Co. fell the most in five weeks in Tokyo trading after U.S. regulators delayed their decision for a second time on whether to approve the company's rheumatoid arthritis drug Actemra.
Roche And FDA Agree On Pathway Towards U.S. Approval Of ACTEMRA® (tocilizumab)
Published December 4, 2008, 9:02 pm, PharmaceuticalOnline
Roche recently announced that the U.S. Food and Drug Administration (FDA) has provided further guidance on the requirements for the Biologics License Application (BLA) for ACTEMRA® (tocilizumab), the first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA).
Chugai Pharma Falls After FDA Seeks Data on Actemra (Update2)
Published December 4, 2008, 7:40 pm, Bloomberg
Dec. 5 (Bloomberg) -- Chugai Pharmaceutical Co. fell the most in seven weeks in Tokyo trading after U.S. regulators delayed their decision for a second time on whether to approve the company's rheumatoid arthritis drug Actemra.
Results From The First And Largest Collaborative Study Confirm Role Of Enbrel® In Psoriatic Arthritis
Published December 4, 2008, 8:16 am, Medical News Today
New data presented today at the 'Gene to Clinic' meeting taking place at the Royal College of Physicians in London, England, reinforce Enbrel's ability to clear skin in patients with psoriatic arthritis, an inflammatory and progressive disease associated with psoriasis.
Results From the First and Largest Collaborative Study Confirm Role of Enbrel(R) in Psoriatic Arthritis
Published December 4, 2008, 2:15 am, Presseportal
Maidenhead, England (ots/PRNewswire) - - New Data Add to the Body of Evidence That Show That Enbrel (Etanercept) Clears Skin and Can Sustain This Efficacy Over Time New data presented today at the 'Gene to Clinic' meeting ...
Roche hit as FDA seeks more data on arthritis drug
Published December 4, 2008, 1:34 am, Reuters via Yahoo! Malaysia News
* U.S. regulators ask for more data on Actemra
(AFX UK Focus) 2008-12-04 08:38 UPDATE 2-U.S. FDA seeks more data on Roche arthritis drug
Published December 4, 2008, 1:06 am, Interactive Investor
ZURICH, Dec 4 (Reuters) - The U.S. Food and Drug Administration (FDA) has asked for further non-clinical data on Roche Holding AG's rheumatoid arthritis drug Actemra before it approves the potential blockbuster. The Swiss group said on Thursday the FDA had requested additional animal model data but ordered no further clinical studies, and that the company would submit the required information in ...
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
Published December 3, 2008, 10:30 pm, PR Newswire via Yahoo! Finance
Roche today announced that the U.S. Food and Drug Administration has provided further guidance on the requirements for the Biologics License Application for ACTEMRA® , the first interleukin-6 receptor-inhibiting monoclonal antibody studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis .
03.12.2008 - DJ HUGIN NEWS/Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented ...
Published December 3, 2008, 4:52 am, 4investors
Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. =--------------------------------------------------------------------- =-------------
Portola Data on Its Novel Syk Inhibitors and Novel Universal Factor Xa Inhibitor Antidote to be Presented at 2008 ...
Published December 3, 2008, 4:30 am, PR Newswire via Yahoo! Finance
Portola Pharmaceuticals, a biopharmaceutical company developing innovative drugs that provide significant advances in cardiovascular disease, inflammatory disease and cancer, today announced that data related to the Company's series of novel compounds that inhibit spleen tyrosine kinase and its novel universal Factor Xa inhibitor antidote will be presented at the annual meeting of the American ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |